SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Emily Dickinson

PatientEmily Dickinson
Date of birth1971-12-10
IdentifiersMRN HR-NI023-SYN; SSN (made up) 000-23-6081
Document date2026-04-20
AuthorLucinda Hartwell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Vomiting and diarrhea for two days (same-day home visit). [S]

History of Present Illness

Ms. Dickinson is a 54-year-old woman with stage G3a A2 chronic kidney disease and hypertension who called this morning and was seen at home the same day. Two days ago she developed nausea, then vomiting four or five times a day and watery diarrhea six times a day; a member of her household had a similar illness last week. She has kept down only sips of water and tea since yesterday. She feels lightheaded when she stands. She has taken all her usual medicines, including losartan 100 mg, dapagliflozin 10 mg, and amlodipine 5 mg, each morning, because she did not remember the sick-day advice. She has had no blood in the stool or vomit, no severe abdominal pain, and no recent antibiotics or travel. She has taken no NSAIDs. She has passed little urine today. [S]

ElementDetail
OnsetTwo days ago, after a household contact with a similar illness
SeverityVomiting four or five times and watery diarrhea six times a day; sips of fluid only
Associated symptomsLightheaded on standing; little urine today; temperature 37.6 °C
MedicinesTook losartan, dapagliflozin, and amlodipine every morning; no NSAIDs
Pertinent negativesNo blood in stool or vomit, severe abdominal pain, recent antibiotics, or travel

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired and weak; low-grade temperature; no rigors
GastrointestinalPositiveNausea, vomiting, and watery diarrhea; mild crampy discomfort; no blood
GenitourinaryPositivePassing little urine; no dysuria or flank pain
CardiovascularNegativeNo chest pain or palpitations; lightheaded only on standing
NeurologicalNegativeNo confusion, headache, or fainting

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen sodium 220 mg oral tablet, two tablets by mouth as needed for headache (over the counter)Two tablets as needed, up to twice a dayOral route2025-10-01 to 2026-01-12stoppedS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12 to 2026-02-02completedS
Losartan 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-02-02activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a dayTwo tablets every 6 hours as needed; maximum 6 tablets a dayOral route2026-01-12activeS
Dapagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-02-02activeS
Amlodipine 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-02activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-20Body height163cmS
2026-04-20Body weight51.9kgS
2026-04-20Body mass index (BMI) [Ratio]19.5kg/m2S
2026-04-20Systolic blood pressure104mm[Hg]S
2026-04-20Diastolic blood pressure64mm[Hg]S
2026-04-20Heart rate102/minS
2026-04-20Respiratory rate18/minS
2026-04-20Body temperature37.6CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-20Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
2026-04-20Potassium [Moles/volume] in Serum or Plasma5.3mmol/L3.5-5.1 mmol/LHighS
2026-04-20Carbon dioxide, total [Moles/volume] in Serum or Plasma20mmol/L22-29 mmol/LLowS
2026-04-20Urea nitrogen [Mass/volume] in Serum or Plasma34mg/dL6-21 mg/dLHighS
2026-04-20Creatinine [Mass/volume] in Serum or Plasma1.66mg/dL0.59-1.04 mg/dLHighS
2026-04-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M36mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-04-20Glucose [Mass/volume] in Serum or Plasma86mg/dL70-99 mg/dLNormalS

Physical Exam

Vital signs recorded on 2026-04-20; see the Vital Signs section. [S]

SystemFinding
GeneralTired, resting in her bedroom chair; alert and oriented
Vital signsSeated 104/64 mmHg, pulse 102; standing after one minute 92/58 mmHg, pulse 116, with lightheadedness; weight 51.9 kg, down 1.7 kg since the last weighing
MouthDry mucous membranes
AbdomenSoft; mild diffuse tenderness without guarding; active bowel sounds
SkinReduced skin turgor; capillary refill 3 seconds
CardiovascularRegular tachycardia; no murmur

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic kidney disease stage G3a A2, attributed to hypertension; synthetic modern diagnosis linked to the Bright's disease entered on her death certificateactiveconfirmed N18.31S — Synthetic modern diagnosis. Bright's disease as her recorded cause of death is documented (D); what it meant in her case is a retrospective question (R), and no kidney test from her lifetime exists.
Hypertension with chronic kidney disease (hypertensive chronic kidney disease, stage 3a); synthetic modern diagnosis linked to the retrospective view that she had severe hypertensionactiveconfirmed I12.9S — Synthetic modern diagnosis; severe hypertension is a retrospective interpretation (R, possible), and no blood pressure from her lifetime exists.
Vitamin D deficiency with a mildly raised PTH in chronic kidney diseaseactiveconfirmed E55.9S — Synthetic laboratory finding at the intake visit.
Viral gastroenteritis with volume depletion and a prerenal rise in creatinine while taking losartan and dapagliflozin; resolvedresolvedconfirmed A08.4S — Synthetic illness at an unscheduled home visit, chosen to teach sick-day rules in chronic kidney disease; it does not echo any documented illness.

Assessment and Plan

Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, and depression monographs (2026)

Follow-up: Nurse telephone call tomorrow; repeat metabolic panel in two to three days; three-month kidney review at home in early June. Next scheduled visit 2026-06-01: home visit for the three-month kidney and blood pressure review. [S]